Interpace Diagnostics Announces New Analyses Showing Positive Impact of PancraGEN™ in the Clinical Management of Pancreatic Cysts
October 19, 2015 at 08:04 AM EDT
PDI, Inc. (NASDAQ: PDII) subsidiary, Interpace Diagnostics, announced data that were presented in two posters during the American ...